Cormedix Inc (CRMD)

SG&A Expense Growth

-19.62%

Quarterly · Period ending:

CRMD logo

CRMD SG&A Expense Growth

Latest reported-19.62%
CRMD Quarterly SG&A Growth (QoQ) (0.00% → -19.62%)
High-resolution chart · PNG

CRMD sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cormedix Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-19.6193%
-13.4648%
8.037%
130.594%
12.1471%
-7.8354%
15.3185%
-10.8147%
-0.6787%
12.9211%
70.7782%
11.3196%
-7.2803%
35.6022%
20.4686%
-8.3905%
6.3359%
4.3441%
18.6748%
14.3282%
-27.0656%
21.4432%
2.6326%
14.1971%
2.1297%
18.1813%
1.7941%
2.3114%
29.5561%
-10.3242%
9.988%
3.4234%
2.2495%
-3.3216%
-1.1915%
-2.8745%
-22.3284%
8.5181%
4.9761%
17.7545%
-8.9857%
216.5028%
-76.8237%
25.1984%
-44.9256%
180.5092%
-3.9151%
-6.8364%
-32.2229%
64.8855%
202.0469%
-44.4802%
64.7034%
5.5846%
23.9308%
11.958%
-29.769%
-0.5523%
-38.5153%
-2.3389%
7.6147%
-24.5383%
72.1802%
3.9624%
-4.4938%
745.9998%
-77.7489%
0.6388%
-15.7628%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.